4//SEC Filing
Becker Todd A 4
Accession 0000905148-25-000867
CIK 0001839341other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 6:23 PM ET
Size
13.1 KB
Accession
0000905148-25-000867
Insider Transaction Report
Form 4
Becker Todd A
Director
Transactions
- Sale
Common Stock
2025-03-03$10.75/sh−134,250$1,443,214→ 195,687 total - Sale
Tranche 1 Warrants
2025-03-03$5.57/sh−10,763$59,942→ 0 totalExercise: $6.81From: 2024-01-23Exp: 2027-01-23→ Common Stock (10,763 underlying) - Sale
Tranche 2 Warrants
2025-03-03$10.86/sh−3,900$42,366→ 5,069 totalExercise: $0.01Exp: 2029-01-23→ Common Stock (3,900 underlying) - Sale
Tranche 2 Warrants
2025-03-04$9.89/sh−5,069$50,152→ 0 totalExercise: $0.01Exp: 2029-01-23→ Common Stock (5,069 underlying)
Footnotes (6)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.50 to $10.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- [F2]Each whole Tranche 1 Warrant entitles the registered holder to purchase one whole share of the Issuer's common stock at an exercise price of $6.81 per share, subject to certain adjustments.
- [F3]The price reported is a weighted average price. These Tranche 1 Warrants were sold in multiple transactions at prices ranging from $5.56 to $5.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Tranche 1 Warrants sold at each separate price within such range.
- [F4]Each whole Tranche 2 Warrant entitles the registered holder to purchase one whole share of the Issuer's common stock at an exercise price of $0.01 per share at any time following the time the volume weighted average price per share of the Issuer's common stock equals or exceeds $8.72 per share on each trading day for 20 consecutive trading days, subject to certain adjustments. The Tranche 2 Warrants became exercisable at the option of the registered holders on July 11, 2024.
- [F5]The price reported is a weighted average price. These Tranche 2 Warrants were sold in multiple transactions at prices ranging from $10.75 to $10.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Tranche 2 Warrants sold at each separate price within such range.
- [F6]The price reported is a weighted average price. These Tranche 2 Warrants were sold in multiple transactions at prices ranging from $9.7867 to $9.955, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Tranche 2 Warrants sold at each separate price within such range.
Documents
Issuer
Core Scientific, Inc./tx
CIK 0001839341
Entity typeother
Related Parties
1- filerCIK 0001447586
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 6:23 PM ET
- Size
- 13.1 KB